MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Operating Expenses 2011-2025 | CSII
Annual Operating Expenses Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 209 M | 210 M | 215 M | 201 M | 175 M | 167 M | 188 M | 175 M | 139 M | 102 M | 77.7 M | 71.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 215 M | 71.3 M | 161 M |
Quarterly Operating Expenses Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.5 M | 53.9 M | 105 M | 51.1 M | 49.6 M | 52.2 M | 102 M | 54.9 M | 50 M | 49.6 M | 50 M | 51.7 M | 58 M | 57.8 M | 58 M | 57.8 M | 48.3 M | 48.7 M | 48.3 M | 48.7 M | 43.4 M | 42.2 M | 43.4 M | 42.2 M | 39.8 M | 42.2 M | 39.8 M | 42.2 M | 48.5 M | 48.3 M | 48.5 M | 48.3 M | 40.6 M | 40.7 M | 40.6 M | 40.7 M | 32.5 M | 29.7 M | 32.5 M | 29.7 M | 24.5 M | 23.2 M | 24.5 M | 23.2 M | 18.8 M | 17.4 M | 18.8 M | 17.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 105 M | 17.4 M | 44.4 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
456 M | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.47 | -3.61 % | $ 120 M | USA |
 |
Boston Scientific Corporation
BSX
|
8.89 B | $ 96.06 | -0.04 % | $ 141 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 9.35 | -1.99 % | $ 671 M |  Israel |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 303.76 | 0.52 % | $ 8.57 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 47.89 | -0.48 % | $ 7.14 K | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 124.72 | -0.1 % | $ 217 B | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.3 | 11.09 % | $ 123 M |  France |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
136 M | $ 14.62 | 1.04 % | $ 1.16 B | Israel |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.21 | 6.14 % | $ 19.5 M | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 62.92 | -0.25 % | $ 3.41 B |  Britain |
 |
Align Technology
ALGN
|
2.19 B | $ 158.62 | 0.49 % | $ 11.9 B | USA |
 |
NanoVibronix
NAOV
|
5.09 M | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.83 | -3.49 % | $ 85.3 M | USA |
|
LENSAR
LNSR
|
32.6 M | $ 12.03 | 0.17 % | $ 139 M | USA |
 |
IRadimed Corporation
IRMD
|
34.4 M | $ 97.53 | 0.48 % | $ 1.24 B | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 14.04 | -3.13 % | $ 379 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 14.51 | -0.13 % | $ 95.1 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 32.87 | 0.7 % | $ 1.45 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
533 M | $ 40.89 | 2.12 % | $ 1.26 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
184 M | $ 17.36 | -0.29 % | $ 401 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 88.38 | -0.15 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 12.65 | -0.08 % | $ 974 M | USA |
 |
Aziyo Biologics
AZYO
|
41.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.58 | 3.61 % | $ 4.03 M | USA |
 |
Myomo
MYO
|
20.9 M | $ 1.02 | - | $ 7.19 M | USA |